Azathioprine induced nodular regenerative hyperplasia in IBD patients

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 5, 2005, Pages 600-603

  Daniel, Fady ^a   Cadranel, Jean François ^b   Seksik, Philippe ^a   Cazier, Alain ^c   Van Huyen, Jean Paul Duong ^a   Ziol, Marianne ^d   Coutarel, Pierre ^b   Loison, Patrick ^b   Jian, Raymond ^a   Marteau, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Service d'Hépato Gastroenterologie et de Diabétologie   (France)

^c Centre Hospitalier de Creil   (France)

^d HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; PURINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ENTERITIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER HYPERPLASIA; MALE; PHARMACOGENETICS; PURINE METABOLISM; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE COUNT; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 20444472032     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)82136-0     Document Type: Short Survey

References (16)

1. Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 2001;15:1699-708.
2. Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine. Am J Gastroenterol 2003; 98:1058-63.
3. Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003;125:298-303.
4. Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D. Nodular regenerative hyperplasia of the liver associated with azathioprine therapy. Gastroenterol Clin Biol 1991;15:968-73.
5. Arnott ID, Ghosh S. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur J Gastroenterol Hepatol 2000;12:569-73.
6. Russmann S, Zimmermann A, Krahenbuhl S, Kern B, Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:287-90.
7. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981;12:60-71.
8. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-13.
9. Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988;83:256-61.
10. Jeurissen ME, Boerbooms AM, van de Putte LB, Kruijsen MW. Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis. Ann Rheum Dis 1990;49:25-7.
11. Romagnuolo J, Sadowski DC, Lalor E, Jewell L, Thomson AB. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Can J Gastroenterol 1998;12:479-83.
12. Colina F, Alberti N, Solis JA, Martinez-Tello FJ. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989;9:253-65.
13. Anthony M, Berg MJ. Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I. J Womens Health Gend Based Med 2002;11:601-15.
14. Dubinsky MC, Yang H, Hassard PV, Seidman EG, Kam LY, Abreu MT, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002;122:904-15.
15. Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, et al. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment Pharmacol Ther 2003;18:401-8.
16. Radomski JS, Chojnacki KA, Moritz MJ, Rubin R, Armenti VT, Wilson GA, et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000;66:1067-70.